Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001578200-26-000004

Director acquired 6,408 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schenkein David P · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-03 Grant or award : show line 1 in the form +6,408 21,665 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-03 Grant or award : show line 2 in the form Stock Option (right to buy) +19,226 19,226 D
Loading xslF345X06/wk-form4_1780692324.xml…